Epithalon (also rendered as Epitalon or Epithalone) is a synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly (AEDG). It was developed based on the compositional profile of Epithalamin, a polypeptide complex isolated from bovine pineal gland tissue, and subsequently identified within that same glandular extract [PMID: 40141333]. Over more than two decades of preclinical investigation, Epithalon has attracted sustained attention in gerontology and neuroendocrinology research for its interactions with multiple cellular and molecular systems.
Research interest in Epithalon centers on its apparent capacity to interface with neuroendocrine signaling pathways, antioxidant enzyme systems, and chromatin-associated structures. Studies have employed in vitro, in vivo, and in silico methodologies, collectively generating a body of data that continues to inform hypotheses about the compound’s underlying mechanisms [PMID: 40141333]. Epithalon is classified for Research Use Only and is investigated strictly in laboratory and preclinical contexts.
Mechanism of Action
Epithalon’s mechanisms, as characterized in the current literature, span several molecular layers. The compound exerts a direct influence on melatonin synthesis within pineal gland models, consistent with its structural derivation from pineal tissue extracts [PMID: 40141333]. Published data also indicate that Epithalon alters mRNA levels of interleukin-2 and modulates the mitogenic activity of murine thymocytes, pointing to interactions with immune-adjacent signaling cascades [PMID: 40141333].
Enzymatic effects documented in research include enhanced activity of acetylcholinesterase (AChE), butyrylcholinesterase (BuChE), and telomerase [PMID: 40141333]. Telomerase activation has attracted particular investigator interest in aging biology given the enzyme’s established role in maintaining chromosomal telomere length. The authors of the 2025 Int J Mol Sci review note, however, that these observations do not necessarily represent the complete set of mechanisms through which Epithalon exerts biological effects [PMID: 40141333].
At the epigenetic level, molecular modeling analyses have shown preferential binding of the AEDG peptide to H1/6 and H1/3 histone subunits at specific sequences (His-Pro-Ser-Tyr-Met-Ala-His-Pro-Ala-Arg-Lys and Tyr-Arg-Lys-Thr-Gln) that interact directly with DNA [doi:10.3390/molecules25030609]. This histone-binding profile has led investigators to propose an epigenetic component underlying some of the peptide’s observed gene-regulatory effects.
In neurogenic differentiation models using human gingival mesenchymal stem cells (hGMSCs), Epithalon increased mRNA expression of Nestin, GAP43, β Tubulin III, and Doublecortin by approximately 1.6–1.8-fold, with corresponding increases in protein synthesis for these neurogenic markers [doi:10.3390/molecules25030609]. These findings position Epithalon as a compound of interest for research into stem cell differentiation pathways.
Research Overview
The bulk of published Epithalon research originates from gerontology and neuroendocrinology laboratories, with significant contributions from the St. Petersburg Institute of Bioregulation and Gerontology. A 2025 systematic review in the International Journal of Molecular Sciences synthesized findings from more than 25 years of study, documenting geroprotective and antioxidant properties alongside antimutagenic effects observed in animal models [PMID: 40141333].
Longevity studies documented by that review suggest Epithalon administration is associated with extended lifespan in rodent models, while separate experimental work reported reductions in experimental cancerogenesis indices [doi:10.3390/molecules25030609]. In retinal and periodontal ligament stem cell preparations, AEDG has been shown to induce neuronal cell differentiation, expanding the research landscape beyond aging biology into neural and regenerative contexts [doi:10.3390/molecules25030609].
Researchers investigating overlapping areas of cellular longevity and neuroendocrine regulation may find it useful to compare Epithalon’s activity profile with that of other studied peptides. GHK-Cu, a copper-binding tripeptide, has been investigated for wound-healing and antioxidant research applications with a distinct tissue-regenerative profile. TB-500 (a synthetic fragment of thymosin β4) is studied in the context of actin dynamics and tissue repair. MOTS-c, a mitochondria-derived peptide, is under active investigation for metabolic signaling properties. ARA-290, a non-hematopoietic erythropoietin analogue, has generated interest in neuroprotection research. Each compound occupies a distinct mechanistic niche, and researchers sometimes examine them in parallel when designing multi-pathway preclinical protocols.
Compound Characteristics
Epithalon is a synthetic tetrapeptide composed of four residues — alanine, glutamic acid, aspartic acid, and glycine (AEDG) — with a molecular weight of approximately 390 Da. This compact sequence contributes to relative chemical tractability in synthesis, though the acidic residues (Glu, Asp) influence solution behavior and formulation considerations relevant to laboratory handling.
Physicochemical and structural investigations of Epithalon remain comparatively limited relative to the volume of biological research published on the compound [PMID: 40141333]. Available data indicate that the peptide demonstrates interactions with histone proteins and DNA-associated chromatin structures under modeling conditions, suggesting conformational preferences consistent with its hypothesized epigenetic activity [doi:10.3390/molecules25030609]. Research-grade Epithalon is typically characterized by HPLC purity analysis and mass spectrometry confirmation prior to incorporation into preclinical study designs.
Epithalon vs Related Compounds
| Feature | Epithalon | GHK-Cu | MOTS-c |
|---|---|---|---|
| Structure | Tetrapeptide (AEDG) | Tripeptide + copper ion | 16-amino-acid mitochondrial peptide |
| Origin | Pineal gland extract–derived | Plasma glycopeptide | Mitochondrial 12S rRNA |
| Primary Research Focus | Neuroendocrine regulation, aging biology, telomerase activity | Wound healing, antioxidant signaling, tissue remodeling | Metabolic signaling, mitochondrial-nuclear crosstalk |
| Proposed Molecular Targets | Histones H1/3 and H1/6; telomerase; AChE/BuChE | Fibronectin receptors; NF-κB pathway | AMPK pathway; nuclear gene regulation |
| Stem Cell Research Interest | Neurogenic differentiation in hGMSCs observed | Skin fibroblast proliferation studied | Skeletal muscle progenitor research ongoing |
| Classification | RUO | RUO | RUO |
Research Availability
Epithalon for research use is available through specialty peptide suppliers that maintain rigorous synthesis and quality-control standards. Researchers sourcing Epithalon should prioritize suppliers that provide certificates of analysis (CoA) with HPLC purity data and mass spectrometry confirmation, as compound integrity is a prerequisite for reproducible preclinical results. Stackhaus Research supplies Epithalon and a range of related research peptides to qualified investigators operating within Research Use Only frameworks, with documentation available to support laboratory procurement processes.
Frequently Asked Questions
What is Epithalon?
Epithalon is a synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly (AEDG), derived from the compositional profile of Epithalamin, a bovine pineal gland polypeptide complex. It has been the subject of preclinical research for over 25 years across in vitro, in vivo, and in silico study designs [PMID: 40141333]. Epithalon is classified strictly for Research Use Only and is not approved for human therapeutic application.
What molecular mechanisms has Epithalon research identified?
Published research has identified several proposed mechanisms, including telomerase activation, modulation of interleukin-2 mRNA levels, and enhanced AChE and BuChE enzymatic activity [PMID: 40141333]. Molecular modeling studies additionally suggest preferential histone-binding activity at H1/3 and H1/6 sites, pointing toward a potential epigenetic regulatory dimension [doi:10.3390/molecules25030609]. Investigators note that the documented mechanisms may not represent a complete account of the compound’s biological activity profile.
How does Epithalon compare to other research peptides?
Epithalon occupies a distinct mechanistic niche relative to compounds such as GHK-Cu, MOTS-c, or TB-500. Where GHK-Cu research is concentrated in tissue remodeling and antioxidant signaling and MOTS-c in mitochondrial metabolic pathways, Epithalon research centers on neuroendocrine regulation, pineal function, and aging biology. Researchers designing multi-target preclinical protocols sometimes evaluate these compounds in parallel given their non-overlapping primary mechanisms.
Is Epithalon of interest for neurogenesis research?
Preclinical data from human gingival mesenchymal stem cell studies indicate that the AEDG peptide increases expression of neurogenic differentiation markers — including Nestin, GAP43, β Tubulin III, and Doublecortin — at both mRNA and protein levels [doi:10.3390/molecules25030609]. These observations have drawn investigator interest in stem cell differentiation research contexts. All such applications are strictly Research Use Only.
Where can researchers source Epithalon?
Research-grade Epithalon is available through specialty peptide suppliers with documented quality-control pipelines. Stackhaus Research provides Epithalon with CoA documentation, including HPLC purity and mass spectrometry data, to support laboratory acquisition requirements. All products are supplied under a Research Use Only designation and are not approved for administration to humans or animals.